Academic to lead preclinical GLP toxicity hub for pharmaceuticals development
South Africa and the North-West University (NWU) are stepping up to develop the African continent’s capabilities to develop its own human vaccines.
The glaring disparities in vaccine access during the Covid-19 pandemic has led to South Africa taking significant strides to bridge the gap between the global north and the African continent's vaccine development needs.